Common, usually mild: Injection-site reactions (redness, swelling, itching), most frequent with both Mild headache, dizziness, or flushing after injection Initial water retention as IGF-1 rises Transient fatigue in the first 12 weeks Less common, dose-dependent: Carpal tunnel-like wrist symptoms (sign IGF-1 may be too high) Joint discomfort or stiffness Numbness or tingling in extremities Elevated blood glucose (GH antagonizes insulin) The monitoring that matters:IGF-1 (insulin-like growth factor 1, the downstream marker of GH activity) is the lab value that tells you whether youre in a therapeutic range or pushing past it
It is well known that cells (particularly immune, lung, reproductive, and brain cells) function optimally when glutathione levels are in peak range
ipamorelin: a separate GHSR agonist with a short human half-life and episodic GH response
Because the body's own production declines with age, illness, and stress, injection therapy is the most direct way to restore intracellular levels